Hostname: page-component-6bf8c574d5-rwnhh Total loading time: 0 Render date: 2025-02-21T08:05:03.105Z Has data issue: false hasContentIssue false
  • English
  • Français

The relevance of recent advances in psychopharmacology for social psychiatry

Published online by Cambridge University Press:  11 October 2011

Malcolm Lader
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials
Information
Epidemiology and Psychiatric Sciences , Volume 7 , Issue 2 , August 1998 , pp. 77 - 81
Copyright
Copyright © Cambridge University Press 1998

References

REFERENCES

Awad, A.G., Voruganti, N.P. & Heslegrave, R.J. (1995). The aims antipsychotic medication. What are they and are they being achieved? CNS Drugs 4, 8–16.Google Scholar
Besnard, F., Avenet, P., Itier, V. et al. (1996). GABAA receptor subtypes and the mechanism of action of zolpidem. In Zolpidem: an Update of its Pharmacological Properties and Therapeutic Place in the Management of Insomnia (ed. Freeman, H., Puech, and Roth, T.), pp. 22–31. Elsevier: Paris.Google Scholar
Brown, S. (1997). Excess mortality of schizophrenia. British Journal of Psychiatry 171, 502–508.CrossRefGoogle ScholarPubMed
Coryell, W., Scheftner, W., Keller, M., Endicott, J., Maser, J. & Klerman, G.L. (1993). The enduring psychosocial consequences mania and depression. American Journal of Psychiatry 150, 720–727.Google ScholarPubMed
Davis, K.L. & Powchik, P. (1995). Tacrine. Lancet 345, 625–630.CrossRefGoogle ScholarPubMed
Gerlach, J. & Casey, D.E. (1988). Tardive dyskinesia. Acta Psychiatrica Scandinavica 77, 369–378.CrossRefGoogle ScholarPubMed
Goldman, S.A. (1996). FDA Medwatch Report: lithium and neuroleptics in combination: the spectrum of neurotoxicity. Psychopharmacology Bulletin 32, 299–309.Google ScholarPubMed
Gray, A. & Fenn, P. (1993). Alzheimer's Disease: the burden of the illness in England. Health Trends 25, 31–37.Google ScholarPubMed
Greenberg, P.E., Stiglin, L.E., Finkelstein, S.N. & Berndt, E. (1993). The economic burden of depression in 1990. Journal of Clinical Psychiatry 54, 405–418.Google ScholarPubMed
Hermann, C.K. (1992). Dementia. A costly problem. Pharmaco-Economics 2, 444–448.CrossRefGoogle ScholarPubMed
Kan, C.C., Breteler, M.H.M. & Zitman, F.G. (1997). High prevalence of benzodiazepine dependence in out-patients users, based on the DSM-III-R and ICD-10 criteria. Acta Psychiatrica Scandinavica 96, 85–93.CrossRefGoogle ScholarPubMed
Lader, M. (ed.) (1992). The Medical Management of Insomnia in General Practice. Round Table Series. Royal Society of Medicine: London.Google Scholar
Leger, D. (1994). The cost of sleep related accidents: a report for the National Commission on Sleep Disorders Research. Sleep 17, 84–93.CrossRefGoogle ScholarPubMed
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. & Stadlan, E.M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939–944.CrossRefGoogle ScholarPubMed
Meltzer, H.Y. (ed.) (1996). Clozapine: A 5-Year Perspective and Clinical Recommendations. Journal of Clinical Psychiatry Monograph Series 14, No. 2.Google Scholar
Meyer-Lindenberg, A., Gruppe, H., Bauer, U., Lis, S., Krieger, S. & Gallhofer, B. (1997). Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: results from a double-blind study. Pharmacopsychiatry 30, 35–42.CrossRefGoogle ScholarPubMed
Morgan, K. (1990). Hypnotics in the elderly: what cause for concern? Drugs 40, 688–696.CrossRefGoogle ScholarPubMed
Quera-Salva, M.A., Orluc, A., Goldenberg, F. et al. (1991). Insomnia and use of hypnotics: study of a French population. Sleep 14, 386–391.CrossRefGoogle ScholarPubMed
Rogers, S.L., Friedhoff, L.T. & the Donepezil Study Group (1996). The efficacy and safety of donepezil in patients with Alzheimer's disease. Results of a US multicentnre, randomized, double-blind, placebo-controlled trial. Dementia 7, 293–303.Google ScholarPubMed
Sokolov, S.T.H. & Joffe, R.T. (1995). Practical guidelines for combination drug therapy of treatment-resistant depression. CNS Drugs 4, 341–350.CrossRefGoogle Scholar
Wells, K.B., Stewart, A., Hays, R.D. et al. (1989). The functioning and well-being of depressed patients. Journal of the American Medical Association 26, 914–919.CrossRefGoogle Scholar